AnaptysBiovsUnitedHealth

ANAB and UNH stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

AnaptysBio (ANAB) has a market value of $1.4B and UnitedHealth (UNH) $300B. Over the last year, with dividends, ANAB moved +92.1% and UNH +8.2%. Dividend yield: ANAB none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ANAB$1.4B

    UNH$300B

    UNH is 217 times ANAB

  • Revenue, 12 months

    ANAB$235M

    UNH$450B

    UNH is 1,917 times ANAB

  • Net income, 12 months

    ANAB-$13M

    UNH$15.9B

  • Operating margin

    ANAB20.4%

    UNH5.3%

    15.1 points apart

  • ROIC

    ANAB–

    UNH11.3%

  • P/E

    ANAB–

    UNH18.9

  • Dividend yield

    ANAB0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    ANAB+125.2%

    UNH-19.5%

    144.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ANAB+125.2%

UNH-19.5%

10020030020222023202420252026
Returns by period
PeriodANABWith dividendsUNHWith dividends
1 year since November 18, 2025+92.1%Price +92.1%+8.2%Price +5.4%
3 years since November 17, 2023+377.3%+68.4% a yearPrice +377.3%-34.4%-13.1% a yearPrice -38.4%
5 years since November 18, 2021+125.2%+17.6% a yearPrice +125.2%-19.5%-4.2% a yearPrice -26.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ANABAnaptysBioUNHUnitedHealth

Valuation

ANABUNH
Valuation
Price$47.40$330.48
Market value$1.4B$300B
Enterprise value (EV)$1.2B$346B
P/E–18.9
P/E, 5-year median–25.0
P/B66.32.9
EV/EBIT25.614.5
Free cash flow yield1.4%7.6%

Results and growth

ANABUNH
Results and growth
Revenue, 12 months$235M$450B
Net income, 12 months-$13M$15.9B
Free cash flow, 12 months$20M$22.8B
Earnings per share, 12 months-$0.46$17.52
Revenue growth, year on year157.0%11.8%
Revenue growth a year, past+25.6%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

ANABUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin20.4%5.3%
Net margin-5.6%3.5%
ROIC–11.3%
ROE-35.6%15.5%

Balance sheet

ANABUNH
Balance sheet
Cash$153M$28.5B
Total debt$13M$74.3B
Net debt / EBITDA-3.21.6
Interest cover–6.2×

Dividends and buybacks

ANABUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield5.0%1.8%
Shareholder yield5.0%4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ANAB or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, AnaptysBio or UnitedHealth?

By market value, UnitedHealth ($300B) is about 217.5 times AnaptysBio ($1.4B), at today's prices.

How did ANAB and UNH stock do over the last 5 years?

Since November 18, 2021, ANAB's price moved +125.2% and UNH's -26.5%. With dividends: ANAB +125.2% (+17.6% a year), UNH -19.5% (-4.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ANAB or UNH?

The dividend yield at today's price is none for AnaptysBio and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, AnaptysBio or UnitedHealth?

Over the last twelve months, the net margin was -5.6% for AnaptysBio and 3.5% for UnitedHealth, and the operating margin 20.4% and 5.3%. Revenue was $235M and $450B.

Which is the better investment, AnaptysBio or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.